Trial · NCT02222545
Adverse events234
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 234
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | AE by System Organ | Infections and infestations | HSCT-TMA-001 High Dose (N=28) | 20 | 28 | |
| other | AE by System Organ | Infections and infestations | aHUS OMS721-TMA-001 Low Dose | 2 | 3 | |
| other | AE by System Organ | Infections and infestations | aHUS OMS721-TMA-001 Medium Dose | 0 | 2 | |
| other | AE by System Organ | Infections and infestations | aHUS OMS721-TMA-001 High Dose | 14 | 20 | |
| other | AE by System Organ | Infections and infestations | TTP OMS721-TMA-001 Medium Dose | 0 | 1 | |
| other | AE by System Organ | Infections and infestations | TTP OMS721-TMA-001 High Dose | 1 | 4 | |
| other | AE by System Organ | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | HSCT-TMA-001 High Dose (N=28) | 3 | 28 | |
| other | AE by System Organ | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | aHUS OMS721-TMA-001 Low Dose | 0 | 3 | |
| other | AE by System Organ | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | aHUS OMS721-TMA-001 Medium Dose | 0 | 2 | |
| other | AE by System Organ | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | aHUS OMS721-TMA-001 High Dose | 1 | 20 | |
| other | AE by System Organ | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | TTP OMS721-TMA-001 Medium Dose | 0 | 1 | |
| other | AE by System Organ | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | TTP OMS721-TMA-001 High Dose | 0 | 4 | |
| other | AE by System Organ | Blood and lymphatic system disorders | HSCT-TMA-001 High Dose (N=28) | 13 | 28 | |
| other | AE by System Organ | Blood and lymphatic system disorders | aHUS OMS721-TMA-001 Low Dose | 0 | 3 | |
| other | AE by System Organ | Blood and lymphatic system disorders | aHUS OMS721-TMA-001 Medium Dose | 0 | 2 | |
| other | AE by System Organ | Blood and lymphatic system disorders | aHUS OMS721-TMA-001 High Dose | 7 | 20 | |
| other | AE by System Organ | Blood and lymphatic system disorders | TTP OMS721-TMA-001 Medium Dose | 0 | 1 | |
| other | AE by System Organ | Blood and lymphatic system disorders | TTP OMS721-TMA-001 High Dose | 2 | 4 | |
| other | AE by System Organ | Immune system disorders | HSCT-TMA-001 High Dose (N=28) | 10 | 28 | |
| other | AE by System Organ | Immune system disorders | aHUS OMS721-TMA-001 Low Dose | 0 | 3 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02222545/events